EFFICACY OF 1.25 MG VERSUS 2.5 MG INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA Six-Month Results of a Randomized Controlled Trial
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Purpose: To evaluate the efficacy of intravitreal injections of two different dosages of bevacizumab (Avastin) for treating diffuse diabetic macular edema.
著者Lam DSC, Lai TYY, Lee VYW, Chan CKM, Liu DTL, Mohamed S, Li CL
期刊名稱RETINA
出版年份2009
月份3
日期1
卷號29
期次3
出版社Lippincott, Williams & Wilkins
頁次292 - 299
國際標準期刊號0275-004X
電子國際標準期刊號1539-2864
語言英式英語
關鍵詞bevacizumab; diabetic macular edema; diabetic retinopathy; dosage; VEGF
Web of Science 學科類別Ophthalmology; OPHTHALMOLOGY

上次更新時間 2021-22-01 於 23:08